Triple

T195378
Position Surface form Disambiguated ID Type / Status
Subject Biogen E3807 entity
Predicate hasProduct P3585 FINISHED
Object Aduhelm
Aduhelm is an Alzheimer’s disease drug developed by Biogen that targets amyloid-beta plaques in the brain.
 E24938 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Aduhelm | Statement: [Biogen, hasProduct, Aduhelm]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Aduhelm
Context triple: [Biogen, hasProduct, Aduhelm]
  • A. Spinraza
    Spinraza is a prescription medication used to treat spinal muscular atrophy (SMA) by modifying SMN2 gene expression to increase production of survival motor neuron (SMN) protein.
  • B. Biogen
    Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
  • C. Plegridy
    Plegridy is a pegylated interferon beta-1a medication used to treat relapsing forms of multiple sclerosis.
  • D. MCI-Shirley
    MCI-Shirley is a medium- and minimum-security state prison for men located in Shirley, Massachusetts.
  • E. Neuralink
    Neuralink is a neurotechnology company developing implantable brain–computer interfaces aimed at enabling direct communication between the human brain and computers.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Aduhelm
Triple: [Biogen, hasProduct, Aduhelm]
Generated description
Aduhelm is an Alzheimer’s disease drug developed by Biogen that targets amyloid-beta plaques in the brain.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Aduhelm
Target entity description: Aduhelm is an Alzheimer’s disease drug developed by Biogen that targets amyloid-beta plaques in the brain.
  • A. Spinraza
    Spinraza is a prescription medication used to treat spinal muscular atrophy (SMA) by modifying SMN2 gene expression to increase production of survival motor neuron (SMN) protein.
  • B. Biogen
    Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
  • C. Plegridy
    Plegridy is a pegylated interferon beta-1a medication used to treat relapsing forms of multiple sclerosis.
  • D. MCI-Shirley
    MCI-Shirley is a medium- and minimum-security state prison for men located in Shirley, Massachusetts.
  • E. Neuralink
    Neuralink is a neurotechnology company developing implantable brain–computer interfaces aimed at enabling direct communication between the human brain and computers.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a2548debd48190ae3a06d6e65b53c6 completed Feb. 28, 2026, 2:35 a.m.
NER Named-entity recognition batch_69a25969425081908e178db8ba4631c2 completed Feb. 28, 2026, 2:56 a.m.
NED1 Entity disambiguation (via context triple) batch_69a3161cdc4c8190bc67683a1a5d39d9 completed Feb. 28, 2026, 4:21 p.m.
NEDg Description generation batch_69a31677d5c48190967cacd20fd6357a completed Feb. 28, 2026, 4:23 p.m.
NED2 Entity disambiguation (via description) batch_69a316d53594819095710388c11624eb completed Feb. 28, 2026, 4:24 p.m.
Created at: Feb. 28, 2026, 2:41 a.m.